Henrik Eriksson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Henrik Eriksson has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Monika Jurkeviciute
Centre for Healthcare Improvement Chalmers University of Technology Gothenburg Sweden
4 shared publications - Anders Fundin
School of Innovation, Design and Engineering, Mälardalen University
3 shared publications - Daniel Gyllenhammar
Halmstad University
3 shared publications - Hendry Raharjo
Division of Service Management and Logistics, Department of Technology Management and Economics, Chalmers University of Technology, Gothenburg, Sweden
3 shared publications - Ida Gremyr
Department of Technology Management and Economics, Chalmers University of Technology, Gothenburg, Sweden
3 shared publications Jonas Hansson
University of Trollhättan/Uddevalla
3 shared publications
Latest Publications
- Open Access
- 31 July 2026
- Published by Taylor & Francis in Public Performance & Management Review
- p. 1-31
Why Improvements Fail in Public Service Ecosystems: Meso-Level Value Co-destruction
Public service ecosystems (PSEs) are complex, multi-actor systems in which value is co-created through the integration of resources among service users, frontline employees, public service organiza...
- 31 July 2026
- Published by Taylor & Francis in Public Performance & Management Review
- p. 1-31
Open AccessWhy Improvements Fail in Public Service Ecosystems: Meso-Level Value Co-destruction
Public service ecosystems (PSEs) are complex, multi-actor systems in which value is co-created through the integration of resources among service users, frontline employees, public service organiza...
- Open Access
- 23 July 2026
- Published by Emerald Publishing in International Journal of Quality & Reliability Management
- p. 1-21
Why improvements fail in the public sector – management models as barrier or enabler for improvements
Purpose: The purpose of this article is to explore the relationship between current public administration and management models and improvements, and especially how management models can be developed to support improvements. Design/methodology/approach: The article takes an action research approach, drawing on data gathered during a four-year improvement initiative set in the public sector and especially the Swedish sick leave system. Findings: By linking empirical data with coexisting public and administration and management, the study shows how current management models in the public sector do not support improvement initiatives. A proposal on how to develop the management models based on a value-centric approach and centred around the beneficiary is presented. The management model for improvement involves a pragmatic approach to problem-solving where leadership is distributed but at the same time adheres to the importance of a system perspective of improvements. Originality/value: This article contributes to practice in terms of highlighting the dysfunctionalities of management models in the public sector, some of which are due to single management models and some due to hybridization between several models. The research develops the knowledge of why improvements fail and what to do about it, enabling future research to further develop management thinking within the public sector.
- 23 July 2026
- Published by Emerald Publishing in International Journal of Quality & Reliability Management
- p. 1-21
Open AccessWhy improvements fail in the public sector – management models as barrier or enabler for improvements
Purpose: The purpose of this article is to explore the relationship between current public administration and management models and improvements, and especially how management models can be developed to support improvements. Design/methodology/approach: The article takes an action research approach, drawing on data gathered during a four-year improvement initiative set in the public sector and especially the Swedish sick leave system. Findings: By linking empirical data with coexisting public and administration and management, the study shows how current management models in the public sector do not support improvement initiatives. A proposal on how to develop the management models based on a value-centric approach and centred around the beneficiary is presented. The management model for improvement involves a pragmatic approach to problem-solving where leadership is distributed but at the same time adheres to the importance of a system perspective of improvements. Originality/value: This article contributes to practice in terms of highlighting the dysfunctionalities of management models in the public sector, some of which are due to single management models and some due to hybridization between several models. The research develops the knowledge of why improvements fail and what to do about it, enabling future research to further develop management thinking within the public sector.
- Open Access
- 23 February 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e60458
Explaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach
Background: Artificial intelligence (AI) is a topic of considerable hype, with many actors sensing its high potential for health care applications. Despite this, the adoption has been slow, with few applications being implemented in clinical practice. Objective: The aim of our study was to investigate the challenges associated with using AI in health care, as well as provide suggestions for how further adoption of AI within health care organizations can be facilitated. Methods: A qualitative case study with a mixed methods approach was conducted at one of Sweden’s largest hospitals. Regulatory approved AI medical devices were analyzed, and primary qualitative data from 14 expert interviews were collected and cross-referenced with secondary quantitative data. The framework of technological innovation systems was used to analyze the system factors and their dynamics to identify blocking mechanisms and areas for improvement. Results: The challenges related to knowledge development, diffusion, legitimation, and resource mobilization could trigger a cascade of positive activities, thereby significantly enhancing the overall performance of the innovation system. Creating dedicated testing environments to evaluate safety and efficacy would facilitate the routine clinical use and reinforce the use of AI innovations in health care organizations. Conclusions: This analysis shows that the adoption of AI health care technology innovations can be accelerated through targeted strategies and supportive mechanisms triggering virtuous cycles that facilitate clinical validation and generate compelling use cases. The interconnection between guidance of search and entrepreneurial experimentation has been confirmed, providing the initial conditions for knowledge development, diffusion, and legitimation in the early stages of emerging technologies.
- 23 February 2026
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 5, e60458
Open AccessExplaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach
Background: Artificial intelligence (AI) is a topic of considerable hype, with many actors sensing its high potential for health care applications. Despite this, the adoption has been slow, with few applications being implemented in clinical practice. Objective: The aim of our study was to investigate the challenges associated with using AI in health care, as well as provide suggestions for how further adoption of AI within health care organizations can be facilitated. Methods: A qualitative case study with a mixed methods approach was conducted at one of Sweden’s largest hospitals. Regulatory approved AI medical devices were analyzed, and primary qualitative data from 14 expert interviews were collected and cross-referenced with secondary quantitative data. The framework of technological innovation systems was used to analyze the system factors and their dynamics to identify blocking mechanisms and areas for improvement. Results: The challenges related to knowledge development, diffusion, legitimation, and resource mobilization could trigger a cascade of positive activities, thereby significantly enhancing the overall performance of the innovation system. Creating dedicated testing environments to evaluate safety and efficacy would facilitate the routine clinical use and reinforce the use of AI innovations in health care organizations. Conclusions: This analysis shows that the adoption of AI health care technology innovations can be accelerated through targeted strategies and supportive mechanisms triggering virtuous cycles that facilitate clinical validation and generate compelling use cases. The interconnection between guidance of search and entrepreneurial experimentation has been confirmed, providing the initial conditions for knowledge development, diffusion, and legitimation in the early stages of emerging technologies.
- Open Access
- 18 November 2025
- Published by Taylor & Francis in Quality Management Journal
- Vol. 33 (1) , 4-22
Challenges and propositions for research in quality management – Relevance gap revisited
- 18 November 2025
- Published by Taylor & Francis in Quality Management Journal
- Vol. 33 (1) , 4-22
Open AccessChallenges and propositions for research in quality management – Relevance gap revisited
- Open Access
- 12 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Explaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach (Preprint)
BACKGROUND Artificial intelligence (AI) is a topic of considerable hype, with many actors sensing its high potential for health care applications. Despite this, the adoption has been slow, with few applications being implemented in clinical practice. OBJECTIVE The aim of our study was to investigate the challenges associated with using AI in health care, as well as provide suggestions for how further adoption of AI within health care organizations can be facilitated. METHODS A qualitative case study with a mixed methods approach was conducted at one of Sweden’s largest hospitals. Regulatory approved AI medical devices were analyzed, and primary qualitative data from 14 expert interviews were collected and cross-referenced with secondary quantitative data. The framework of technological innovation systems was used to analyze the system factors and their dynamics to identify blocking mechanisms and areas for improvement. RESULTS The challenges related to knowledge development, diffusion, legitimation, and resource mobilization could trigger a cascade of positive activities, thereby significantly enhancing the overall performance of the innovation system. Creating dedicated testing environments to evaluate safety and efficacy would facilitate the routine clinical use and reinforce the use of AI innovations in health care organizations. CONCLUSIONS This analysis shows that the adoption of AI health care technology innovations can be accelerated through targeted strategies and supportive mechanisms triggering virtuous cycles that facilitate clinical validation and generate compelling use cases. The interconnection between guidance of search and entrepreneurial experimentation has been confirmed, providing the initial conditions for knowledge development, diffusion, and legitimation in the early stages of emerging technologies.
- 12 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExplaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach (Preprint)
BACKGROUND Artificial intelligence (AI) is a topic of considerable hype, with many actors sensing its high potential for health care applications. Despite this, the adoption has been slow, with few applications being implemented in clinical practice. OBJECTIVE The aim of our study was to investigate the challenges associated with using AI in health care, as well as provide suggestions for how further adoption of AI within health care organizations can be facilitated. METHODS A qualitative case study with a mixed methods approach was conducted at one of Sweden’s largest hospitals. Regulatory approved AI medical devices were analyzed, and primary qualitative data from 14 expert interviews were collected and cross-referenced with secondary quantitative data. The framework of technological innovation systems was used to analyze the system factors and their dynamics to identify blocking mechanisms and areas for improvement. RESULTS The challenges related to knowledge development, diffusion, legitimation, and resource mobilization could trigger a cascade of positive activities, thereby significantly enhancing the overall performance of the innovation system. Creating dedicated testing environments to evaluate safety and efficacy would facilitate the routine clinical use and reinforce the use of AI innovations in health care organizations. CONCLUSIONS This analysis shows that the adoption of AI health care technology innovations can be accelerated through targeted strategies and supportive mechanisms triggering virtuous cycles that facilitate clinical validation and generate compelling use cases. The interconnection between guidance of search and entrepreneurial experimentation has been confirmed, providing the initial conditions for knowledge development, diffusion, and legitimation in the early stages of emerging technologies.
- Open Access
- 22 February 2022
- Published by Taylor & Francis in Total Quality Management & Business Excellence
- Vol. 34 (1-2) , 201-219
Theory and practice of customer-related improvements: a systematic literature review
Customers are vital to any organization and system, and must therefore be considered when seeking to improve. However, how to improve with regard to the customer, is not clear, and the knowledge is spread over several research fields, making it difficult for researchers and practitioners to comprehend. The purpose of this literature review is to show how customer-related improvements are described in the literature and how the research is performed. 666 articles were screened, resulting in 99 coded and analysed articles. The study concludes that there is a lack of understanding when it comes to the process of how to improve and that both practitioners and academics should focus more on the system level. It is also seen that by involving the customer in the improvement process, the improvement is more likely to succeed. The article concludes that there is a need for future research which are conceptual, longitudinal, and are addressing actual improvements, not just potential. From the practitioners’ point of view, the article is proposing an increased focus on customer-related improvements which address aspects concerning people, such as employee competence and work environment, and reward systems, rather than strategy and processes to improve the potential benefits.
- 22 February 2022
- Published by Taylor & Francis in Total Quality Management & Business Excellence
- Vol. 34 (1-2) , 201-219
Open AccessTheory and practice of customer-related improvements: a systematic literature review
Customers are vital to any organization and system, and must therefore be considered when seeking to improve. However, how to improve with regard to the customer, is not clear, and the knowledge is spread over several research fields, making it difficult for researchers and practitioners to comprehend. The purpose of this literature review is to show how customer-related improvements are described in the literature and how the research is performed. 666 articles were screened, resulting in 99 coded and analysed articles. The study concludes that there is a lack of understanding when it comes to the process of how to improve and that both practitioners and academics should focus more on the system level. It is also seen that by involving the customer in the improvement process, the improvement is more likely to succeed. The article concludes that there is a need for future research which are conceptual, longitudinal, and are addressing actual improvements, not just potential. From the practitioners’ point of view, the article is proposing an increased focus on customer-related improvements which address aspects concerning people, such as employee competence and work environment, and reward systems, rather than strategy and processes to improve the potential benefits.
- Open Access
- 16 October 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (10) , e17720
Identifying the Value of an eHealth Intervention Aimed at Cognitive Impairments: Observational Study in Different Contexts and Service Models
Background: Value is one of the central concepts in health care, but it is vague within the field of summative eHealth evaluations. Moreover, the role of context in explaining the value is underexplored, and there is no explicit framework guiding the evaluation of the value of eHealth interventions. Hence, different studies conceptualize and operationalize value in different ways. Objective: The objective of our study is to identify contextual factors that determine similarities and differences in the value of an eHealth intervention between 2 contexts. We also aim to reflect on and contribute to the discussion about the specification, assessment, and relativity of the “value” concept in the evaluation of eHealth interventions. Methods: The study concerned a 6-month eHealth intervention targeted at elderly patients (n=107) diagnosed with cognitive impairment in Italy and Sweden. The intervention introduced a case manager role and an eHealth platform to provide remote monitoring and coaching services to the patients. A model for evaluating the value of eHealth interventions was designed as monetary and nonmonetary benefits and sacrifices, based on the value conceptualizations in eHealth and marketing literature. The data was collected using the Mini–Mental State Examination (MMSE), the clock drawing test, and the 5-level EQ-5D (EQ-5D-5L). Semistructured interviews were conducted with patients and health care professionals. Monetary data was collected from the health care and technology providers. Results: The value of an eHealth intervention applied to similar types of populations but differed in different contexts. In Sweden, patients improved cognitive performance (MMSE mean 0.85, SD 1.62, P<.001), reduced anxiety (EQ-5D-5L mean 0.16, SD 0.54, P=.046), perceived their health better (EQ-5D-5L VAS scale mean 2.6, SD 9.7, P=.035), and both patients and health care professionals were satisfied with the care. However, the Swedish service model demonstrated an increased cost, higher workload for health care professionals, and the intervention was not cost-efficient. In Italy, the patients were satisfied with the care received, and the health care professionals felt empowered and had an acceptable workload. Moreover, the intervention was cost-effective. However, clinical efficacy and quality of life improvements have not been observed. We identified 6 factors that influence the value of eHealth intervention in a particular context: (1) service delivery design of the intervention (process of delivery), (2) organizational setup of the intervention (ie, organizational structure and professionals involved), (3) cost of different treatments, (4) hourly rates of staff for delivering the intervention, (5) lifestyle habits of the population (eg, how physically active they were in their daily life and if they were living alone or with family), and (6) local preferences on the quality of patient care. Conclusions: Value in the assessments of eHealth interventions need to be considered beyond economic terms, perceptions, or behavior changes. To obtain a holistic view of the value created, it needs to be operationalized into monetary and nonmonetary outcomes, categorizing these into benefits and sacrifices.
- 16 October 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (10) , e17720
Open AccessIdentifying the Value of an eHealth Intervention Aimed at Cognitive Impairments: Observational Study in Different Contexts and Service Models
Background: Value is one of the central concepts in health care, but it is vague within the field of summative eHealth evaluations. Moreover, the role of context in explaining the value is underexplored, and there is no explicit framework guiding the evaluation of the value of eHealth interventions. Hence, different studies conceptualize and operationalize value in different ways. Objective: The objective of our study is to identify contextual factors that determine similarities and differences in the value of an eHealth intervention between 2 contexts. We also aim to reflect on and contribute to the discussion about the specification, assessment, and relativity of the “value” concept in the evaluation of eHealth interventions. Methods: The study concerned a 6-month eHealth intervention targeted at elderly patients (n=107) diagnosed with cognitive impairment in Italy and Sweden. The intervention introduced a case manager role and an eHealth platform to provide remote monitoring and coaching services to the patients. A model for evaluating the value of eHealth interventions was designed as monetary and nonmonetary benefits and sacrifices, based on the value conceptualizations in eHealth and marketing literature. The data was collected using the Mini–Mental State Examination (MMSE), the clock drawing test, and the 5-level EQ-5D (EQ-5D-5L). Semistructured interviews were conducted with patients and health care professionals. Monetary data was collected from the health care and technology providers. Results: The value of an eHealth intervention applied to similar types of populations but differed in different contexts. In Sweden, patients improved cognitive performance (MMSE mean 0.85, SD 1.62, P<.001), reduced anxiety (EQ-5D-5L mean 0.16, SD 0.54, P=.046), perceived their health better (EQ-5D-5L VAS scale mean 2.6, SD 9.7, P=.035), and both patients and health care professionals were satisfied with the care. However, the Swedish service model demonstrated an increased cost, higher workload for health care professionals, and the intervention was not cost-efficient. In Italy, the patients were satisfied with the care received, and the health care professionals felt empowered and had an acceptable workload. Moreover, the intervention was cost-effective. However, clinical efficacy and quality of life improvements have not been observed. We identified 6 factors that influence the value of eHealth intervention in a particular context: (1) service delivery design of the intervention (process of delivery), (2) organizational setup of the intervention (ie, organizational structure and professionals involved), (3) cost of different treatments, (4) hourly rates of staff for delivering the intervention, (5) lifestyle habits of the population (eg, how physically active they were in their daily life and if they were living alone or with family), and (6) local preferences on the quality of patient care. Conclusions: Value in the assessments of eHealth interventions need to be considered beyond economic terms, perceptions, or behavior changes. To obtain a holistic view of the value created, it needs to be operationalized into monetary and nonmonetary outcomes, categorizing these into benefits and sacrifices.
- Open Access
- 28 August 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (8) , e17718
Exploring the Use of Evidence From the Development and Evaluation of an Electronic Health (eHealth) Trial: Case Study
Background: Evidence-based practice refers to building clinical decisions on credible research evidence, professional experience, and patient preferences. However, there is a growing concern that evidence in the context of electronic health (eHealth) is not sufficiently used when forming policies and practice of health care. In this context, using evaluation and research evidence in clinical or policy decisions dominates the discourse. However, the use of additional types of evidence, such as professional experience, is underexplored. Moreover, there might be other ways of using evidence than in clinical or policy decisions. Objective: This study aimed to analyze how different types of evidence (such as evaluation outcomes [including patient preferences], professional experiences, and existing scientific evidence from other research) obtained within the development and evaluation of an eHealth trial are used by diverse stakeholders. An additional aim was to identify barriers to the use of evidence and ways to support its use. Methods: This study was built on a case of an eHealth trial funded by the European Union. The project included 4 care centers, 2 research and development companies that provided the web-based physical exercise program and an activity monitoring device, and 2 science institutions. The qualitative data collection included 9 semistructured interviews conducted 8 months after the evaluation was concluded. The data analysis concerned (1) activities and decisions that were made based on evidence after the project ended, (2) evidence used for those activities and decisions, (3) in what way the evidence was used, and (4) barriers to the use of evidence. Results: Evidence generated from eHealth trials can be used by various stakeholders for decisions regarding clinical integration of eHealth solutions, policy making, scientific publishing, research funding applications, eHealth technology, and teaching. Evaluation evidence has less value than professional experiences to local decision making regarding eHealth integration into clinical practice. Professional experiences constitute the evidence that is valuable to the highest variety of activities and decisions in relation to eHealth trials. When using existing scientific evidence related to eHealth trials, it is important to consider contextual relevance, such as location or disease. To support the use of evidence, it is suggested to create possibilities for health care professionals to gain experience, assess a few rather than a large number of variables, and design for shorter iterative cycles of evaluation. Conclusions: Initiatives to support and standardize evidence-based practice in the context of eHealth should consider the complexities in how the evidence is used in order to achieve better uptake of evidence in practice. However, one should be aware that the assumption of fact-based decision making in organizations is misleading. In order to create better chances that the evidence produced would be used, this should be addressed through the design of eHealth trials.
- 28 August 2020
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 22 (8) , e17718
Open AccessExploring the Use of Evidence From the Development and Evaluation of an Electronic Health (eHealth) Trial: Case Study
Background: Evidence-based practice refers to building clinical decisions on credible research evidence, professional experience, and patient preferences. However, there is a growing concern that evidence in the context of electronic health (eHealth) is not sufficiently used when forming policies and practice of health care. In this context, using evaluation and research evidence in clinical or policy decisions dominates the discourse. However, the use of additional types of evidence, such as professional experience, is underexplored. Moreover, there might be other ways of using evidence than in clinical or policy decisions. Objective: This study aimed to analyze how different types of evidence (such as evaluation outcomes [including patient preferences], professional experiences, and existing scientific evidence from other research) obtained within the development and evaluation of an eHealth trial are used by diverse stakeholders. An additional aim was to identify barriers to the use of evidence and ways to support its use. Methods: This study was built on a case of an eHealth trial funded by the European Union. The project included 4 care centers, 2 research and development companies that provided the web-based physical exercise program and an activity monitoring device, and 2 science institutions. The qualitative data collection included 9 semistructured interviews conducted 8 months after the evaluation was concluded. The data analysis concerned (1) activities and decisions that were made based on evidence after the project ended, (2) evidence used for those activities and decisions, (3) in what way the evidence was used, and (4) barriers to the use of evidence. Results: Evidence generated from eHealth trials can be used by various stakeholders for decisions regarding clinical integration of eHealth solutions, policy making, scientific publishing, research funding applications, eHealth technology, and teaching. Evaluation evidence has less value than professional experiences to local decision making regarding eHealth integration into clinical practice. Professional experiences constitute the evidence that is valuable to the highest variety of activities and decisions in relation to eHealth trials. When using existing scientific evidence related to eHealth trials, it is important to consider contextual relevance, such as location or disease. To support the use of evidence, it is suggested to create possibilities for health care professionals to gain experience, assess a few rather than a large number of variables, and design for shorter iterative cycles of evaluation. Conclusions: Initiatives to support and standardize evidence-based practice in the context of eHealth should consider the complexities in how the evidence is used in order to achieve better uptake of evidence in practice. However, one should be aware that the assumption of fact-based decision making in organizations is misleading. In order to create better chances that the evidence produced would be used, this should be addressed through the design of eHealth trials.
- Open Access
- 7 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Identifying the Value of an eHealth Intervention Aimed at Cognitive Impairments: Observational Study in Different Contexts and Service Models (Preprint)
BACKGROUND Value is one of the central concepts in health care, but it is vague within the field of summative eHealth evaluations. Moreover, the role of context in explaining the value is underexplored, and there is no explicit framework guiding the evaluation of the value of eHealth interventions. Hence, different studies conceptualize and operationalize value in different ways. OBJECTIVE The objective of our study is to identify contextual factors that determine similarities and differences in the value of an eHealth intervention between 2 contexts. We also aim to reflect on and contribute to the discussion about the specification, assessment, and relativity of the “value” concept in the evaluation of eHealth interventions. METHODS The study concerned a 6-month eHealth intervention targeted at elderly patients (n=107) diagnosed with cognitive impairment in Italy and Sweden. The intervention introduced a case manager role and an eHealth platform to provide remote monitoring and coaching services to the patients. A model for evaluating the value of eHealth interventions was designed as monetary and nonmonetary benefits and sacrifices, based on the value conceptualizations in eHealth and marketing literature. The data was collected using the Mini–Mental State Examination (MMSE), the clock drawing test, and the 5-level EQ-5D (EQ-5D-5L). Semistructured interviews were conducted with patients and health care professionals. Monetary data was collected from the health care and technology providers. RESULTS The value of an eHealth intervention applied to similar types of populations but differed in different contexts. In Sweden, patients improved cognitive performance (MMSE mean 0.85, SD 1.62, P<.001), reduced anxiety (EQ-5D-5L mean 0.16, SD 0.54, P=.046), perceived their health better (EQ-5D-5L VAS scale mean 2.6, SD 9.7, P=.035), and both patients and health care professionals were satisfied with the care. However, the Swedish service model demonstrated an increased cost, higher workload for health care professionals, and the intervention was not cost-efficient. In Italy, the patients were satisfied with the care received, and the health care professionals felt empowered and had an acceptable workload. Moreover, the intervention was cost-effective. However, clinical efficacy and quality of life improvements have not been observed. We identified 6 factors that influence the value of eHealth intervention in a particular context: (1) service delivery design of the intervention (process of delivery), (2) organizational setup of the intervention (ie, organizational structure and professionals involved), (3) cost of different treatments, (4) hourly rates of staff for delivering the intervention, (5) lifestyle habits of the population (eg, how physically active they were in their daily life and if they were living alone or with family), and (6) local preferences on the quality of patient care. CONCLUSIONS Value in the assessments of eHealth interventions need to be considered beyond economic terms, perceptions, or behavior changes. To obtain a holistic view of the value created, it needs to be operationalized into monetary and nonmonetary outcomes, categorizing these into benefits and sacrifices.
- 7 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessIdentifying the Value of an eHealth Intervention Aimed at Cognitive Impairments: Observational Study in Different Contexts and Service Models (Preprint)
BACKGROUND Value is one of the central concepts in health care, but it is vague within the field of summative eHealth evaluations. Moreover, the role of context in explaining the value is underexplored, and there is no explicit framework guiding the evaluation of the value of eHealth interventions. Hence, different studies conceptualize and operationalize value in different ways. OBJECTIVE The objective of our study is to identify contextual factors that determine similarities and differences in the value of an eHealth intervention between 2 contexts. We also aim to reflect on and contribute to the discussion about the specification, assessment, and relativity of the “value” concept in the evaluation of eHealth interventions. METHODS The study concerned a 6-month eHealth intervention targeted at elderly patients (n=107) diagnosed with cognitive impairment in Italy and Sweden. The intervention introduced a case manager role and an eHealth platform to provide remote monitoring and coaching services to the patients. A model for evaluating the value of eHealth interventions was designed as monetary and nonmonetary benefits and sacrifices, based on the value conceptualizations in eHealth and marketing literature. The data was collected using the Mini–Mental State Examination (MMSE), the clock drawing test, and the 5-level EQ-5D (EQ-5D-5L). Semistructured interviews were conducted with patients and health care professionals. Monetary data was collected from the health care and technology providers. RESULTS The value of an eHealth intervention applied to similar types of populations but differed in different contexts. In Sweden, patients improved cognitive performance (MMSE mean 0.85, SD 1.62, P<.001), reduced anxiety (EQ-5D-5L mean 0.16, SD 0.54, P=.046), perceived their health better (EQ-5D-5L VAS scale mean 2.6, SD 9.7, P=.035), and both patients and health care professionals were satisfied with the care. However, the Swedish service model demonstrated an increased cost, higher workload for health care professionals, and the intervention was not cost-efficient. In Italy, the patients were satisfied with the care received, and the health care professionals felt empowered and had an acceptable workload. Moreover, the intervention was cost-effective. However, clinical efficacy and quality of life improvements have not been observed. We identified 6 factors that influence the value of eHealth intervention in a particular context: (1) service delivery design of the intervention (process of delivery), (2) organizational setup of the intervention (ie, organizational structure and professionals involved), (3) cost of different treatments, (4) hourly rates of staff for delivering the intervention, (5) lifestyle habits of the population (eg, how physically active they were in their daily life and if they were living alone or with family), and (6) local preferences on the quality of patient care. CONCLUSIONS Value in the assessments of eHealth interventions need to be considered beyond economic terms, perceptions, or behavior changes. To obtain a holistic view of the value created, it needs to be operationalized into monetary and nonmonetary outcomes, categorizing these into benefits and sacrifices.
- Open Access
- 7 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Exploring the Use of Evidence From the Development and Evaluation of an Electronic Health (eHealth) Trial: Case Study (Preprint)
BACKGROUND Evidence-based practice refers to building clinical decisions on credible research evidence, professional experience, and patient preferences. However, there is a growing concern that evidence in the context of electronic health (eHealth) is not sufficiently used when forming policies and practice of health care. In this context, using evaluation and research evidence in clinical or policy decisions dominates the discourse. However, the use of additional types of evidence, such as professional experience, is underexplored. Moreover, there might be other ways of using evidence than in clinical or policy decisions. OBJECTIVE This study aimed to analyze how different types of evidence (such as evaluation outcomes [including patient preferences], professional experiences, and existing scientific evidence from other research) obtained within the development and evaluation of an eHealth trial are used by diverse stakeholders. An additional aim was to identify barriers to the use of evidence and ways to support its use. METHODS This study was built on a case of an eHealth trial funded by the European Union. The project included 4 care centers, 2 research and development companies that provided the web-based physical exercise program and an activity monitoring device, and 2 science institutions. The qualitative data collection included 9 semistructured interviews conducted 8 months after the evaluation was concluded. The data analysis concerned (1) activities and decisions that were made based on evidence after the project ended, (2) evidence used for those activities and decisions, (3) in what way the evidence was used, and (4) barriers to the use of evidence. RESULTS Evidence generated from eHealth trials can be used by various stakeholders for decisions regarding clinical integration of eHealth solutions, policy making, scientific publishing, research funding applications, eHealth technology, and teaching. Evaluation evidence has less value than professional experiences to local decision making regarding eHealth integration into clinical practice. Professional experiences constitute the evidence that is valuable to the highest variety of activities and decisions in relation to eHealth trials. When using existing scientific evidence related to eHealth trials, it is important to consider contextual relevance, such as location or disease. To support the use of evidence, it is suggested to create possibilities for health care professionals to gain experience, assess a few rather than a large number of variables, and design for shorter iterative cycles of evaluation. CONCLUSIONS Initiatives to support and standardize evidence-based practice in the context of eHealth should consider the complexities in how the evidence is used in order to achieve better uptake of evidence in practice. However, one should be aware that the assumption of fact-based decision making in organizations is misleading. In order to create better chances that the evidence produced would be used, this should be addressed through the design of eHealth trials.
- 7 January 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessExploring the Use of Evidence From the Development and Evaluation of an Electronic Health (eHealth) Trial: Case Study (Preprint)
BACKGROUND Evidence-based practice refers to building clinical decisions on credible research evidence, professional experience, and patient preferences. However, there is a growing concern that evidence in the context of electronic health (eHealth) is not sufficiently used when forming policies and practice of health care. In this context, using evaluation and research evidence in clinical or policy decisions dominates the discourse. However, the use of additional types of evidence, such as professional experience, is underexplored. Moreover, there might be other ways of using evidence than in clinical or policy decisions. OBJECTIVE This study aimed to analyze how different types of evidence (such as evaluation outcomes [including patient preferences], professional experiences, and existing scientific evidence from other research) obtained within the development and evaluation of an eHealth trial are used by diverse stakeholders. An additional aim was to identify barriers to the use of evidence and ways to support its use. METHODS This study was built on a case of an eHealth trial funded by the European Union. The project included 4 care centers, 2 research and development companies that provided the web-based physical exercise program and an activity monitoring device, and 2 science institutions. The qualitative data collection included 9 semistructured interviews conducted 8 months after the evaluation was concluded. The data analysis concerned (1) activities and decisions that were made based on evidence after the project ended, (2) evidence used for those activities and decisions, (3) in what way the evidence was used, and (4) barriers to the use of evidence. RESULTS Evidence generated from eHealth trials can be used by various stakeholders for decisions regarding clinical integration of eHealth solutions, policy making, scientific publishing, research funding applications, eHealth technology, and teaching. Evaluation evidence has less value than professional experiences to local decision making regarding eHealth integration into clinical practice. Professional experiences constitute the evidence that is valuable to the highest variety of activities and decisions in relation to eHealth trials. When using existing scientific evidence related to eHealth trials, it is important to consider contextual relevance, such as location or disease. To support the use of evidence, it is suggested to create possibilities for health care professionals to gain experience, assess a few rather than a large number of variables, and design for shorter iterative cycles of evaluation. CONCLUSIONS Initiatives to support and standardize evidence-based practice in the context of eHealth should consider the complexities in how the evidence is used in order to achieve better uptake of evidence in practice. However, one should be aware that the assumption of fact-based decision making in organizations is misleading. In order to create better chances that the evidence produced would be used, this should be addressed through the design of eHealth trials.